Replication fork stalling can promote genomic instability, predisposing to cancer and other diseases 1-3 . Stalled replication forks may be processed by sister chromatid recombination (SCR), generating error-free or error-prone homologous recombination (HR) outcomes 4-8 . In mammalian cells, a long-standing hypothesis proposes that the major hereditary breast/ovarian cancer predisposition gene products, BRCA1 and BRCA2, control HR/SCR at stalled replication forks 9 . Although BRCA1 and BRCA2 affect replication fork processing 10-12 , direct evidence that BRCA gene products regulate homologous recombination at stalled chromosomal replication forks is lacking, due to a dearth of tools for studying this process. Here we report that the Escherichia coli Tus/Ter complex [13] [14] [15] [16] can be engineered to induce site-specific replication fork stalling and chromosomal HR/SCR in mouse cells. Tus/Ter-induced homologous recombination entails processing of bidirectionally arrested forks. We find that the Brca1 carboxy (C)-terminal tandem BRCT repeat and regions of Brca1 encoded by exon 11-two Brca1 elements implicated in tumour suppressioncontrol Tus/Ter-induced homologous recombination. Inactivation of either Brca1 or Brca2 increases the absolute frequency of 'longtract' gene conversions at Tus/Ter-stalled forks, an outcome not observed in response to a site-specific endonuclease-mediated chromosomal double-strand break. Therefore, homologous recombination at stalled forks is regulated differently from homologous recombination at double-strand breaks arising independently of a replication fork. We propose that aberrant long-tract homologous recombination at stalled replication forks contributes to genomic instability and breast/ovarian cancer predisposition in BRCA mutant cells.
Replication fork stalling can promote genomic instability, predisposing to cancer and other diseases [1] [2] [3] . Stalled replication forks may be processed by sister chromatid recombination (SCR), generating error-free or error-prone homologous recombination (HR) outcomes [4] [5] [6] [7] [8] .
In mammalian cells, a long-standing hypothesis proposes that the major hereditary breast/ovarian cancer predisposition gene products, BRCA1 and BRCA2, control HR/SCR at stalled replication forks 9 . Although BRCA1 and BRCA2 affect replication fork processing [10] [11] [12] , direct evidence that BRCA gene products regulate homologous recombination at stalled chromosomal replication forks is lacking, due to a dearth of tools for studying this process. Here we report that the Escherichia coli Tus/Ter complex [13] [14] [15] [16] can be engineered to induce site-specific replication fork stalling and chromosomal HR/SCR in mouse cells. Tus/Ter-induced homologous recombination entails processing of bidirectionally arrested forks. We find that the Brca1 carboxy (C)-terminal tandem BRCT repeat and regions of Brca1 encoded by exon 11-two Brca1 elements implicated in tumour suppressioncontrol Tus/Ter-induced homologous recombination. Inactivation of either Brca1 or Brca2 increases the absolute frequency of 'longtract' gene conversions at Tus/Ter-stalled forks, an outcome not observed in response to a site-specific endonuclease-mediated chromosomal double-strand break. Therefore, homologous recombination at stalled forks is regulated differently from homologous recombination at double-strand breaks arising independently of a replication fork. We propose that aberrant long-tract homologous recombination at stalled replication forks contributes to genomic instability and breast/ovarian cancer predisposition in BRCA mutant cells.
Tus binds the 23 base pair (bp) Ter site to induce polar replication fork arrest in E. coli [13] [14] [15] [16] . To determine whether Tus/Ter can arrest mammalian replisomes, we introduced six TerB sites into a plasmid containing the Epstein-Barr virus nuclear antigen 1 (EBNA1)-binding origin of replication (p63TerOri, Fig. 1a ). EBNA1 recruits mammalian replication factors, mediating predominantly unidirectional plasmid replication, due to a replication block at EBNA1-bound FR (family of repeats) 17 . In p63TerOri, the major clockwise fork approaches the 'non-permissive' (fork-stalling) face of Tus/Ter (Fig. 1a ). We used two-dimensional DNA gel electrophoresis with Southern blotting 18 to visualize replication through 63Ter. Transfection of 293E cells, which express EBNA1 (ref. 19) , with p63TerOri and control empty vector revealed plasmid replication intermediates (arc A, Fig. 1b ). Co-transfection of p63TerOri and myc-tagged Tus revealed site-specific stalling of the clockwise fork (spot B, Fig. 1b , c and Extended Data Fig. 1 ). TusH144A, a Ter-binding-impaired mutant 16 , induced minimal fork stalling. Reversal of 63Ter to the 'permissive' orientation (63REVTer, Fig. 1b ) also supported Tus-dependent stalling of the clockwise fork, albeit less efficiently than non-permissive 63Ter (Fig. 1b, c) . The FR/EBNA1 replication block is incomplete 20 . A weaker Tus/Ter-dependent double-Y spot (C, Fig. 1b and Extended Data Fig. 1 ) reflects bidirectional fork arrest at 63Ter. We estimate the FR/ EBNA1 and Tus/63Ter replication block efficiencies as ,70% (Extended Fig. 2 ). Thus, Tus/Ter mediates bidirectional site-specific arrest of mammalian replication forks.
To determine whether Tus/Ter induces HR/SCR at a defined chromosomal locus in mammalian cells, we placed 63Ter in a homologous recombination reporter of short-and long-tract gene conversion (termed STGC and LTGC, respectively) between sister chromatids 21 . Duplication of a red fluorescent protein (RFP) cassette distinguishes LTGC (length $ 1252 bp; GFP 1 RFP 1 )fromSTGC (length ,1,252 bp; GFP 1 RFP -; Fig. 2a ) 21 . 63Ter abuts an I-SceI site, interrupting an enhanced green fluorescent protein gene (63Ter-I-SceI-GFP, Fig. 2a ). Recombination of the stalled left-hand fork ( Fig. 2a ) with the 59-truncated GFP copy (Tr-GFP) of the sister chromatid generates wild-type GFP. If chromosomal fork arrest were bidirectional, this could produce a two-ended break, generating predominantly STGCs ( Fig. 2a and Extended Data Fig. 3a ) 21 . In contrast, unidirectional fork arrest with one-ended breaks would favour LTGC, and any STGCs arising from one-ended breaks would necessarily be terminated by non-canonical mechanisms (Extended Data Fig. 3b ) 21 .
We targeted the 63Ter/HR reporter as a single copy to the ROSA26 locus of mouse embryonic stem (ES) cell line 11CO/47T (Brca1 fl/BRCT ) 21 . Brca1 BRCT encodes a C-terminal truncated protein; the BRCT-encoding elements of Brca1 fl can be conditionally deleted (generating Brca1 D ) 21 . Indeed, Tus, but not TusH144A, induced HR within 63Ter/HR Brca1 fl/BRCT cells, the major HR product being STGC (Fig. 2b) . Tus failed to induce HR in Brca1 fl/BRCT cells containing a ROSA26-targeted HR reporter lacking the Ter array ( Fig. 2b) 21 . Thus, Tus/Ter-induced chromosomal HR requires cognate Tus-Ter binding. The ratio LTGC/total HR, a measure of the probability that HR resolves as LTGC, was ,7% in three independent Tus-transfected clones ( Fig. 2c and Extended Data Fig. 4a ). Three additional independent clones of Brca1 fl/BRCT ES cells, each containing a single-copy randomly integrated chromosomal 63Ter/HR reporter, behaved similarly (Extended Data Fig. 4b ). The predominance of STGC and the consistent results at different loci suggested that Tus/Ter-induced HR entails bidirectional fork arrest (Extended Data Fig. 3a ). We resolved this definitively by Southern blot analysis of Tus/Ter-induced STGCs. Unidirectional fork arrest/breakage (Extended Data Fig. 3b ) could produce a one-ended break, generating STGC products of variable size 21 . In contrast, bidirectional fork arrest ( Fig. 2a and Extended Data Fig. 3a ) could produce a two-ended break, with STGC termination by annealing. This would generate STGC products of fixed size, resembling the parental reporter but lacking the 63Ter array or I-SceI site ( Fig. 2a) 21 . Indeed, 44/44 Tus/Ter-induced STGCs in 63Ter/HR reporter Brca1 fl/BRCT cells revealed this latter structure ( Fig. 2d ). As expected, I-SceI-induced HR behaved similarly ( Fig. 2d ). A second arrested fork (right-hand fork, Fig. 2a ) must provide the homologous second end during Tus/Terinduced STGC. Therefore, Tus/Ter-induced STGC is the product of bidirectional replication fork arrest. Overall, I-SceI-induced HR in Brca1 fl/BRCT 63Ter/HR reporter cells was ,20% of that in isogenic ROSA26-targeted Brca1 fl/BRCT HR reporter cells, which lack a 63Ter array (data not shown) 21 . The reasons for this difference are unclear.
To investigate further the non-polar behaviour of Tus/Ter in mammalian HR, we studied the Tus mutant F140A that binds duplex Ter with higher affinity than Tus but is defective for the Ter C-6 base-flipping 'locking' mechanism that contributes to polar fork arrest in E. coli 16 . TusF140A induced higher levels of HR than Tus in 63Ter/HR Brca1 fl/BRCT cells (Extended Data Fig. 4c, d) , showing that the C-6 'lock' is dispensable for Tus/Ter-induced HR in mammalian cells. This might be explained by the different polarities of the E. coli DnaB and vertebrate MCM replicative helicases. Ter C-6 is located on the leading strand of the fork approaching the non-permissive end of Ter. Unlike DnaB, which translocates along the lagging strand, the MCM helicase translocates along the leading strand and might occlude Ter C-6 within its barrel, thereby denying Tus access to the C-6 lock mechanism. To determine the minimal number of Tus/Ter complexes needed for HR induction, we generated reporters containing 3, 2 or 1 Ter sites (Extended Data Fig. 4e ). We targeted each, in parallel, as a single copy to the ROSA26 locus of Brca1 fl/BRCT ES cells and found that a minimum of 3 Ter sites is required for robust Tus-induced HR (Extended Data Fig. 4f ). We inverted the 63Ter array orientation to generate a 63REVTer/HR reporter. When targeted as a single copy to the ROSA26 locus of Brca1 fl/BRCT ES cells, this reporter supported Tus-induced HR as robustly as the 63Ter/HR reporter (Extended Data Fig. 4f ). Our findings do not exclude a polar component to Tus/Ter-induced fork stalling on a mammalian chromosome but this polarity, if present, is relative and not absolute.
Interstrand DNA crosslink repair of plasmids replicating in Xenopus laevis egg extracts entails endonucleolytic attack of bidirectionally stalled forks 22 . Interestingly, Tus/Ter-induced HR was suppressed by depletion of the endonuclease scaffold Slx4/FancP 23, 24 to a greater extent than I-SceI-induced HR (Extended Data Fig. 5 ), indicating that Slx4 contributes specifically to Tus/Ter-induced HR. However, it is not clear whether Slx4 mediates endonucleolytic attack of stalled forks during 
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Tus/Ter-induced HR. Work in Schizosaccharomyces pombe suggests that alternative mechanisms, such as template switching, could mediate HR at stalled mammalian forks 7 .
To determine whether BRCA1 regulates HR at stalled replication forks, we transduced 63Ter/HR Brca1 fl/BRCT cells with adeno-Cre and screened for Brca1 loss (Fig. 3a) . The resulting Brca1 D/BRCT cells are viable hypomorphs with growth characteristics similar to Brca1 fl/BRCT cells 21 . We studied Tus-induced HR in three independent Cre-treated clones of each genotype ( Fig. 3) . Surprisingly, Tus-induced STGC in 63Ter/HR Brca1 D/BRCT cells showed no reduction compared to Brca1 fl/BRCT cells, but LTGC was elevated twofold (Fig. 3b ). Correspondingly, the probability of engaging LTGC during Tus/Ter-induced HR was doubled to ,15% (Fig. 3b ). Consistent with our recent findings, I-SceI-induced HR in 63Ter/HR Brca1 D/BRCT cells was diminished and biased in favour of LTGC ( Fig. 3b) 21 . Southern blot analysis of Tus/Ter-induced STGC and LTGC products in 63Ter/HR Brca1 D/BRCT cells revealed patterns similar to Brca1 fl/BRCT cells (Extended Data Fig. 6 ). However, in Brca1 D/BRCT cells, 6/41 (15%) Tus/Ter-induced STGC and 3/15 (20%) LTGC clones retained an additional copy of the parental reporter (Extended Data Fig. 6 ). This was not separable by recloning, suggesting that it was retained by non-disjunction. A total of 4/41 (9.8%) I-SceI-induced STGC Brca1 D/BRCT clones revealed non-disjunction; thus, non-disjunction is not specific to Tus/Ter-induced HR. The fact that the donor sister was unaltered during LTGC excludes crossing-over as a cause of the LTGC outcome in these clones 25, 26 .
We asked whether Brca1 domains additional to the BRCT repeat regulate Tus/Ter-induced HR. Indeed, short interfering (siRNA)-mediated Brca1 depletion suppressed STGC but increased LTGC in both Brca1 fl/BRCT and Brca1 D/BRCT cells (Extended Data Fig. 7 ). In Brca1-depleted Brca1 D/BRCT cells, ,40% of all HR products were LTGCs. More than half of the BRCA1 polypeptide is encoded by exon 11, which is a target of inactivating germline mutations in hereditary breast/ovarian cancer; exon 11 is also alternatively spliced, generating an in-frame nuclear Dexon11 gene product that retains an N-terminal RING domain and C-terminal BRCT functions 27 . To test whether Brca1 exon 11 regulates Tus/Ter-induced HR, we targeted a single copy of the 63Ter/HR reporter to the ROSA26 locus of mouse Brca1 fl/Exon11 ES cells. The Brca1 Exon11 allele lacks exon 11; exon 11 of Brca1 fl can be conditionally deleted to generate Brca1 D (Fig. 4a ) 28 . Note that Brca1 fl and Brca1 D denote distinct Brca1 alleles in the two Brca1 conditional systems described here. Following adeno-Cre treatment, we retrieved 63Ter/HR Brca1 fl/Exon11 and 63Ter/HR Brca1 D/Exon11 clones. Each of three independent 63Ter/HR Brca1 D/Exon11 clones revealed reduced Tus/Ter-induced STGC but increased absolute frequencies of LTGC in comparison with three independent 63Ter/ HR Brca1 fl/Exon11 clones (Fig. 4b ). Deletion of Brca1 exon 11 increased the probability of engaging Tus/Ter-induced LTGC ,4-fold to ,30% (Fig. 4b) . In contrast, the absolute frequency of I-SceI-induced LTGC was reduced in Brca1 D/Exon11 cells and ,20% of HR products were 
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LTGCs (Fig. 4b) . Thus, Brca1 exon 11 contributes to Tus/Ter-induced HR both quantitatively and qualitatively.
To determine whether BRCA2/Rad51 regulates Tus/Ter-induced HR, we used siRNA to deplete Brca2 or Rad51 during HR induction. Depletion of Brca2 suppressed Tus/Ter-induced STGC but elevated LTGC frequencies in both Brca1 fl/BRCT and Brca1 D/BRCT cells (Extended Data Fig. 8 ). In Brca1 fl/BRCT and Brca1 D/BRCT cells depleted of Brca2, ,30% and ,50% respectively of all Tus/Ter-induced HR products were LTGCs, whereas the equivalent probabilities for Rad51-depleted cells were ,40% and ,70% (Extended Data Fig. 9 ). Thus, suppression of LTGC at stalled forks is a shared function of BRCA1, BRCA2 and Rad51. Inhibition of 53BP1 partially reversed defective I-SceI-induced HR in Brca1 D/BRCT cells, as expected 21 , but did not affect Tus/Ter-induced HR in either Brca1 fl/BRCT or Brca1 D/BRCT cells (Extended Data Fig. 10 ). This suggests that BRCA1's functions in Tus/Ter-induced and SceI-induced HR are, in part, distinct. LTGC at stalled forks may include pathological responses analogous to break-induced replication in yeast 3, 8, 29, 30 . Our work identifies loss of BRCA1/BRCA2/Rad51-dependent suppression of LTGC at stalled replication forks as a potential contributor to breast/ ovarian cancer predisposition.
METHODS SUMMARY
A description of the molecular biology methods, cell culture and recombination assays can be found in the full Methods.
Online Content Any additional Methods, Extended Data display items and Source Data are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
Molecular biology, siRNAs and antibodies. The vector for mammalian expression of myc epitope-tagged, nuclear localized, codon-optimized wild-type Tus (pCMVb myc-NLS-Tus), vectors p63TerOri and p63REVTerOri and the Ter HR reporters were constructed by conventional cloning methods using a previously described RFP-SCR reporter 31 . Ter-containing plasmids were cultivated in JJC33 (Tus 2 ) strains of E. coli. siRNA SMARTpools were purchased from Dharmacon. Cells were lysed in RIPA buffer (50 mM Tris-HCl, pH 8.0, 250 mM NaCl, 0.1% sodium dodecyl sulphate, 1% NP-40 containing protease and phosphatase inhibitors PMSF and Roche complete protease inhibitor tablet). Extracted protein was resolved by 4-12% bis-Tris SDS-PAGE (Invitrogen) and analysed by immunoblotting using the following antibodies; Brca1 (a gift of the Baer laboratory, 1:100), beta-tubulin (Abcam ab6046, 1:4,000), beta-actin (Abcam ab8226, 1:10,000), Myc (Abcam ab9106, 1:10,000), hRad51 (aliquot B32, 1:500), and HA (Santa Cruz sc-805, 1:200). Cell lines and cell culture. Mouse embryonic stem (ES) cells were grown in ES medium on either MEF feeders or gelatinized plates as described previously [31] [32] [33] . A total of 10 mg of the 63Ter HR reporter ROSA26 targeting plasmid was linearized by KpnI digest and introduced by electroporation to 1 3 10 7 to 2 3 10 7 cells and subsequently seeded on 6-cm plates with puromycin-resistant feeders. Plates were supplemented with puromycin (4 mg ml 21 ) 24 h later and colonies were picked 5-10 days later. ROSA26 targeted lines were screened for by PCR and verified by Southern blotting 31 . We generated multiple Brca1-deficient ES clones by transient adenovirus-mediated Cre expression. ROSA26 genotyping primers: ROSA26-sense: CA TCAAGGAAACCCTGGACTACTG; TerB36 HR reporter antisense: CCTCGG CTAGGTAGGGGATC. The Brca1 exon11 status was determined by PCR. Brca1 59 sense: CTGGGTAGTTTGTAAGCATCC; Brca1 exon11 antisense: CAATAA ACTGCTGGTCTCAGGC; Brca1 exon11 sense: GGAAATGGCAACTTGCCT AG; Brca1 39 antisense: CTGCGAGCAGTCTTCAGAAAG. Recombination assays. A total of 1.6 3 10 5 cells were transfected in suspension with 0.5 mg pcDNA3b-myc NLS-I-SceI 34 , pcDNA3b-myc NLS-Tus, pcDNA3b-myc NLS-TusH144A, pcDNA3b-myc NLS-TusF140A, or control vector using Lipofectamine 2000 (Invitrogen). GFP 1 and GFP 1 RFP 1 frequencies were scored 3 days after transfection by flow cytometry using a Becton Dickinson 5 Laser LSRII in triplicate and values presented corrected for background events and transfection efficiency. Transfection efficiency was measured by parallel transfection with 0.05 mg of wild-type GFP expression vector and 0.45 mg control vector. Typically 6 3 10 5 total events were scored per sample. Tus or I-SceI expression vector transfection efficiencies were typically between 50% and 75%, and background levels of HR products typically , 0.005% for GFP 1 RFP 2 and , 0.001% for GFP 1 RFP 1 (for example, Extended Data Fig. 4a, b) . Statistical methods. Each figure legend reports the sample size in terms of number of replicates per experiment and number of experiments that were analysed to generate the data shown. For statistical analysis of HR values, the arithmetic mean of triplicate samples was calculated for each independent experiment (that is, experiments performed on different days) and these single data points for each experiment were used to calculate the mean and standard deviation between experiments. The standard error of the mean (s.e.m.) was calculated as standard deviation/!n, where n 5 number of experiments (not number of replicates). For example, if we measured triplicate samples in four different independent experiments, then n 5 4. Differences between groups were analysed by Student's two-tailed unpaired t-test, assuming unknown variance, using GraphPad Prism v5.0d software. P values are given in the figure legends. Densitometry of two-dimensional gel data was also analysed by calculation of arithmetic mean and s.e.m. and analysis by Student's t-test. Analysis of trend in Extended Data Fig. 4f was performed by ANOVA using GraphPad Prism v5.0d software, in addition to the t-test as described above. qRT-PCR analysis. RNA from transfected ES cells was extracted by Qiagen RNeasy Mini Kit (Qiagen Sciences) 2 days post-transfection. First-strand cDNA analysis was performed on an ABI 7300 Real time PCR System using Power SYBR Green RNA-toC T 1-Step Kit (Applied Biosystems). TaqMan probe and primer sets to genotype for Brca1 were: Brca1 Exon 22-23 sense: TTCCGTGGTGAAGGAGCTT; Brca1 Exon 22-23 antisense: TGGCTGCACGATCACAAC; Brca1 Exon 23-24 sense: GCCTGGACAGAAGACAGCA; Brca1 Exon 23-24 antisense: CAGTCCCACA TCACAAGACG; Brca1 Exon 22-23 TaqMan probe FAM-CGCTCACCCATGA CACAGGTGC-BHQ; Brca1 Exon 23-24 TaqMan probe-FAM-TGCACAGCT GCCCAATATCTGGG-BHQ). Conventional SYBR green qRT-PCR assays of Gapdh and siRNA-targeted gene was performed. We used the NIH NCI Nucleotide utility to Primer 3 software (Whitehead Institute, MIT) to generate gene-specific primer sequences for mouse Brca1 and Gapdh. We used the NIH NCI Nucleotide utility to generate gene-specific primer sequences for mouse Slx4, Slx1, Eme1 and Xpf (also known as Ercc4). Primers for RT-PCR were Brca1-exon 21-22 sense: ATG AGCTGGAGAGGATGCTG; Brca1 exon 21-22 antisense: CTGGGCAGTTGCT GTCTTCT; Brca1 exon 22-23 sense: GGTGCTCATCTAGTTGTGATCG; Brca1 exon 22-23 antisense: CTGTACCAGGTAGGCATCCA; Brca1 exon 7-8 sense: AGCCTAGGTGTCCAGCTGTC; Brca1 exon 7-8-antisense: CTGCAATCACC TGGCTTAGTT; Brca2 sense: TCTGCCACTGTGAAAAATGC; Brca2 antisense: TCAAGCTGGGCTGAAGATT; Slx4 sense: GTGGGACGACTGGAATGAGG; Slx4 antisense: GCACCTTTTGGTGTCTCTGG; Slx1 sense: GGATGGACCAT GCAGCAAGA; Slx1 antisense: CCATTCAAACCGAAGGGCG; Eme1 sense: AG GCCAGAGGAATGCCTGAA; Eme1 antisense: CCAGTCATCTCCATCCTCT ACC; Xpf sense: TGGTCAGAATTCAGGTTGGC; Xpf antisense: TTTCAGGAC GTCAGTCAGCG. The mRNA was measured in triplicates with a standard curve generated for each gene using cDNA obtained from each sample. The expression level of target genes was normalized to internal Gapdh. 293 cell transfection and episome two-dimensional gel electrophoresis. A total of 12 3 10 6 293E (ATCC CRL-10852) cells were plated per 15-cm dish 1 day before transfection. Cells were transfected with 4.5 mg pOri plasmids and 1 mg of control empty vector or pcDNA3b-myc NLS-Tus in antibiotic free media using Lipofectamine2000 reagent, and media changed 24 h after transfection. Then 40 h after transfection, plates were rinsed with 13 PBS and cells washed off the plate with ice-cold PBS, washed again with ice-cold PBS and HIRT extracted as described below. Purified DNA was restriction digested 8-16 h and run on a 14 3 16 cm 0.4% agar 0.1 mg ml 21 ethidium bromide 0.53 TBE gel 13 h in the dark at 40 V. First dimension gel slabs were cut out and embedded in the second dimension slab gel (20 3 25 cm 1% agar, 0.53TBE, 1 mg ml 21 ethidium bromide) and run at 160 V for 7.5 h in the cold room at 4 uC. HIRT episome extraction from 293 cells. The plasmid was extracted as published 35 . Briefly, PBS-washed 293HEK or 293E cells were lysed in 2.25 ml 0.6% sodium dodecyl sulphate 33 mM Tris-HCl, 6 mM EDTA, 66 mg ml 21 RNase followed by digestion with 0.5 mg proteinase K for 90 min at 37 uC. Samples were subject to brief, 20 s, base extraction with 0.75 ml 0.1 M NaOH and proteins precipitated by addition of 1 ml 4.2 M Gu-HCl, 0.9 M potassium acetate pH 4.8. Cell debris was pelleted at 39,000g and supernatant loaded onto a Qiagen Miniprep spin column (Qiagen Sciences, Maryland). Columns were washed with 0.5 ml Qiagen Buffer PB (5 M Gu-HCl, 30% ethanol, adding 10 mM Tris-HCl pH 6.6) and 0.75 ml Qiagen Buffer PE (10 mM Tris-HCl pH 7.5, 80% ethanol) and plasmid DNA eluted using two volumes of 40 ml Qiagen EB buffer. Southern blotting. Southern blotting of genomic DNA was performed using GFP cDNA or ROSA26 59 probes as described previously 33, 34 . For all experiments, including mouse ES cells containing a randomly integrated reporter not at ROSA26, clones containing only one intact copy of the reporter were used. Genomic DNA was extracted from confluent ES cells on 6-well plates (,5 3 10 6 to 10 3 10 6 cells) using a Puregene DNA Isolation Kit (Gentra Systems). Episomal plasmid DNA was extracted by HIRT extraction described above and Southern blotting performed using random labelled probe produced from the KpnI/HindIII restriction fragment of p63TerOri. experiments performed with p63Ter-2Ori. Methods as in Fig. 1b . Note presence of four stall spots in p63Ter-2Ori replicating in presence of Tus. Double Y stall spots C and C2 and background signal C' were quantified. Note that the shape and size of each area is identical within an individual experiment, but varies between experiments. By considering only double Y stall spots (that is, in which FR/EBNA1 bypass has occurred), the relative abundance of the double Y stall spots C and C2 are used to estimate the efficiency of the Tus/63Ter replication fork barrier. Let a 5 probability of the 63Ter array blocking the fork and b 5 probability of 63Ter bypass. Then a 1 b 5 1. The probability of the two 63Ter arrays blocking each fork on one p63Ter-2Ori plasmid (generating spot C2) is a 2 . The probability of one 63Ter array being blocked and the second array being bypassed (generating spot C) is 2ab. Relative densitometry of spots C and C2 (each with subtraction of background C') shows that spot C contributes 49.6% and C2 contributes 50.4% (s.e.m. 5.6%). Therefore 0.496a 2 5 0.504 3 2ab. Solving this, a 5 0.67 Therefore the estimated efficiency of the Tus/63Ter replication fork block within the replicating plasmid is 67%. Note that the efficiency of the Tus/63Ter replication fork block within the chromosome is unknown.
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Extended Data Figure 3 Error bars represent s.e.m. Tus-induced HR: Student's t-test of siSlx4 versus siLuc: P 5 0.0219; siSlx4 versus siSlx1: P 5 0.0012; siSlx4 versus siSlx4 1 Slx1: P 5 0.5983; siSlx4 versus siEme1: P 5 0.0171; siSlx4 versus siSlx4 1 siEme1: P 5 0.8721; siSlx4 versus siXpf: P 5 0.0098; siSlx4 versus siSlx4 1 siXpf: P 5 0.4711; siSlx1 versus siLuc: P 5 0.9332; siEme1 versus siLuc: P 5 0.4631; siXpf versus siLuc: P 5 0.7818; siSlx4 1 siSlx1 versus siLuc: P 5 0.0155; siSlx4 1 siEme1 versus siLuc: P 5 0.0215; siSlx4 1 siXpf versus siLuc: P 5 0.0305. I-SceI-induced HR: Student's t-test of siSlx4 versus siLuc: P 5 0.0907; siSlx4 versus siSlx1: P 5 0.0195; siSlx4 versus siSlx4 1 siSlx1: P 5 0.4897; siSlx4 versus siEme1: P 5 0.0568; siSlx4 versus siSlx4 1 siEme1: P 5 0.3411; siSlx4 versus siXpf: P 5 0.0745; siSlx4 versus siSlx4 1 siXpf: P 5 0.2726; siSlx1 versus siLuc: P 5 0.9198; siEme1 versus siLuc: P 5 0.3349; siXpf versus siLuc: P 5 0.9217; siSlx4 1 siSlx1 versus siLuc: P 5 0.1521; siSlx4 1 siEme1 versus siLuc: P 5 0.2864; siSlx4 1 siXpf versus siLuc: to homologous recombination at stalled replication forks. a, Frequencies of Tus-induced and I-SceI-induced HR in Brca1 fl/BRCT and Brca1 D/BRCT 63Ter/ HR cells transiently co-transfected with Tus, or I-SceI and with either control Luciferase siRNA (siLuc) or Brca2 SMARTpool (siBrca2). Each column represents the mean of triplicate samples for each independent clone from five independent experiments (that is, n 5 5). Error bars represent s.e.m. Tusinduced HR, Brca1 fl/BRCT cells, Student's t-test siBrca2 versus siLuc: STGC: P 5 0.0031; LTGC: P 5 0.0007; LTGC/total HR: P 5 0.0042; Brca1 D/BRCT cells, siBrca2 versus siLuc: STGC: P 5 0.0040; LTGC: P 5 0.0013; LTGC/total HR: P 5 0.0006. I-SceI-induced HR, Brca1 fl/BRCT cells, Student's t-test siBrca2 versus siLuc: STGC: P 5 0.0028; LTGC: P 5 0.0456; LTGC/total HR: P 5 0.7945; Brca1 D/BRCT cells, siBrca2 versus siLuc: STGC: P 5 0.0010; LTGC: P 5 0.2926; LTGC/total HR: P 5 0.0316. b, qRT-PCR analysis of Brca2 mRNA in siRNA-treated cells as shown.
Extended Data Figure 9 | Rad51 contributes quantitatively and qualitatively to homologous recombination at stalled replication forks. a, Frequencies of Tus-induced and I-SceI-induced HR in Brca1 fl/BRCT and Brca1 D/BRCT 63Ter/HR cells transiently co-transfected with Tus, or I-SceI and with either control Luciferase siRNA (siLuc) or Rad51 SMARTpool (siRad51). Each column represents the mean of triplicate samples for each independent clone from seven independent experiments for Brca1 fl/BRCT (that is, n 5 7) and four independent experiments for Brca1 D/BRCT cells (that is, n 5 4). Error bars represent s.e.m. Tus-induced HR, Brca1 fl/BRCT cells, Student's t-test siRad51 versus siLuc: STGC: P , 0.0001; LTGC: P 5 0.1578; LTGC/total HR: P 5 0.0002; Brca1 D/BRCT cells, siRad51 versus siLuc: STGC: P 5 0.0010; LTGC: P 5 0.0676; LTGC/total HR: P , 0.0001. I-SceI-induced HR, Brca1 fl/BRCT cells, Student's t-test siRad51 versus siLuc: STGC: P 5 0.0014; LTGC: P 5 0.0002; LTGC/total HR: P 5 0.6216; Brca1 D/BRCT cells, siRad51 versus siLuc: STGC: P 5 0.0068; LTGC: P 5 0.2064; LTGC/total HR: P 5 0.0186. b, Rad51 protein levels and b-tubulin loading control in Brca1 fl/BRCT and Brca1 D/BRCT siRNAtreated cells as shown.
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